Cardia, M.C.; Carta, A.R.; Caboni, P.; Maccioni, A.M.; Erbì, S.; Boi, L.; Meloni, M.C.; Lai, F.; Sinico, C.
Trimethyl Chitosan Hydrogel Nanoparticles for Progesterone Delivery in Neurodegenerative Disorders. Pharmaceutics 2019, 11, 657.
https://doi.org/10.3390/pharmaceutics11120657
AMA Style
Cardia MC, Carta AR, Caboni P, Maccioni AM, Erbì S, Boi L, Meloni MC, Lai F, Sinico C.
Trimethyl Chitosan Hydrogel Nanoparticles for Progesterone Delivery in Neurodegenerative Disorders. Pharmaceutics. 2019; 11(12):657.
https://doi.org/10.3390/pharmaceutics11120657
Chicago/Turabian Style
Cardia, Maria Cristina, Anna Rosa Carta, Pierluigi Caboni, Anna Maria Maccioni, Sara Erbì, Laura Boi, Maria Cristina Meloni, Francesco Lai, and Chiara Sinico.
2019. "Trimethyl Chitosan Hydrogel Nanoparticles for Progesterone Delivery in Neurodegenerative Disorders" Pharmaceutics 11, no. 12: 657.
https://doi.org/10.3390/pharmaceutics11120657
APA Style
Cardia, M. C., Carta, A. R., Caboni, P., Maccioni, A. M., Erbì, S., Boi, L., Meloni, M. C., Lai, F., & Sinico, C.
(2019). Trimethyl Chitosan Hydrogel Nanoparticles for Progesterone Delivery in Neurodegenerative Disorders. Pharmaceutics, 11(12), 657.
https://doi.org/10.3390/pharmaceutics11120657